Matthew T. Gunnison

Matt is Co-Founder and President of Gamma Biosciences LLC, an investment platform formed in partnership with KKR & Co. focused on next-generation bioprocessing technologies and manufacturing for advanced therapies.

Matt oversees the Gamma portfolio and is responsible for identifying and executing investments as well as driving growth, strategic and operational initiatives across Gamma’s operating companies. Matt was most recently Global Head of Business Development for GE Healthcare, where he was responsible for M&A and strategic alliances across the $19B healthcare division of GE. Matt joined GE in 2011 and held a variety of other leadership positions in strategy, business development, venture investing and new business creation.

Matt began his career as a corporate attorney at Sidley Austin LLP. He holds a J.D. from the University of Michigan and a B.A. in Economics from Georgetown University.